Muscular Dystrophy – Modus Health

PUBLICATIONS

M. E. Busse, C. M. Wiles, R. W. van Deursen. Community walking activity in neurological disorders with leg weakness. J Neurol Neurosurg Psychiatry 2006; 77(3):359-62.

C. M. McDonald, L. M. Widman, D. D. Walsh, S. A. Walsh, R. T. Abresch. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2005; 86(4):802-8.

H. A. Hayes, D. Dibella, R. Crockett, M. Dixon, R. J. Butterfield, N. E. Johnson. Stepping Activity in Children With Congenital Myotonic Dystrophy. Pediatr Phys Ther 2018; 30(4):335-339.

M. E. Busse, O. R. Pearson, R. Van Deursen, C. M. Wiles. Quantified measurement of activity provides insight into motor function and recovery in neurological disease. J Neurol Neurosurg Psychiatry 2004; 75(6):884-8.

E. G. Fowler, L. A. Staudt, K. R. Heberer, et al. Longitudinal community walking activity in Duchenne muscular dystrophy. Muscle Nerve 2018; 57(3):401-406.

C. M. McDonald. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 2002; 81(11 Suppl):S108-20.

Z. E. Davidson, M. M. Ryan, A. J. Kornberg, K. Z. Walker, H. Truby. Strong Correlation Between the 6-Minute Walk Test and Accelerometry Functional Outcomes in Boys With Duchenne Muscular Dystrophy. J Child Neurol 2014.

K. J. Nolan, M. Yarossi, A. Ramanujam. Measuring ambulation in adults with central neurologic disorders. Phys Med Rehabil Clin N Am 2013; 24(2):247-63.

A. Govoni, F. Magri, S. Brajkovic, et al. Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy. Cell Mol Life Sci 2013; 70(23):4585-602.

S. Oftedal, K. L. Bell, L. E. Mitchell, P. S. Davies, R. S. Ware, R. N. Boyd. A systematic review of the clinimetric properties of habitual physical activity measures in young children with a motor disability. Int J Pediatr 2012; 2012:976425.